Olabisi Lab
The Mission of our lab is to discover fundamental mechanisms by which APOL1 dysregulates normal cellular function,with the goal of preventing and curing APOL1-mediated kidney disease.
Our Research
To Understand the mechanisms by which APOL1 cause kidney disease and discover novel prevention and cure for
APOL1-mediated kidney disease, we leverage several research strategies.
Basic Research
Human stem cell models and APOL1-transgenic mouse model enable investigation of disease mechanisms and drug discovery
Translational Research
Human-derived tissues and data inform the study of disease penetrance and drug discovery
Clinical Research
Community-engaged clinical trials enable us to translate fundamental discoveries to impactful interventions
Team
Somenath Datta, PhD
Senior Research Associate
Opeyemi Olabisi MD, PhD
Principal Investigator
Guojie Li, PhD
Research Scientist
Karen Soldano
Senior Lab Research Analyst, Lab Manager
Daniel Silas
Research Technician II
Maurice Smith, MS
Senior Clinical Research Coordinator
Leshon Matthews
Senior Clinical Research Specialist
Monique Dacanay
Research Intern
